Related Experiment Video
Updated: Nov 30, 2025

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Systematic expression analysis of EAF family reveals the importance of EAF2 in melanoma
1Department of Burn and Plastic Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215000, PR China; Department of Surgery, Soochow University, Suzhou 215000, PR China.
Background:
Skin cutaneous melanoma (SKCM) accounts for over 75% of skin cancer-related deaths each year. EAF2, as a member of EAF family, has been found in several cancers, however, the role of EAF2 in SKCM is rarely studied.
Methods:
In this study, we utilized multiple bioinformatics tools to systematically analyze the expression of EAF family and investigate the prognostic value of EAF2 in melanoma.
Results:
We found both transcriptional and proteomics expression expressions of EAF2 were elevated in SKCM. Survival analysis and ROC curves showed significant diagnostic and prognostic ability of EAF2. Importantly, EAF2 expression was closely associated with the immune-infiltrating levels of B cells, CD4+ T, CD8+ T, neutrophils, macrophages and dendritic cells. Co-expression analysis showed EAF2 has a strong positive correlation with CD19, implying they may be functional partners in the immune response of SKCM.
Conclusions:
In summary, our study is the first to reveal that increased expression of EAF2 is significantly correlated with tumor progression and better prognosis in SKCM patients. The role of EAF2 in SKCM demonstrated that it might be a potential and promising biomarker for the diagnosis and prediction of prognosis in patients with SKCM.
Insights
Elevated EAF2 expression is linked to better outcomes in skin cutaneous melanoma (SKCM). This study highlights EAF2 as a promising biomarker for SKCM diagnosis and prognosis, potentially aiding immune response understanding.
Area of Science:
- Oncology
- Dermatology
- Immunology
Background:
- Skin cutaneous melanoma (SKCM) is a leading cause of cancer death.
- The role of EAF2 in SKCM has not been well-established.
- EAF2 family members are implicated in various cancers.
Purpose of the Study:
- To analyze EAF2 expression in SKCM.
- To investigate the diagnostic and prognostic value of EAF2 in melanoma.
- To explore the association between EAF2 and immune infiltration in SKCM.
Main Methods:
- Bioinformatics analysis of EAF family expression.
- Prognostic value assessment using survival analysis and ROC curves.
- Correlation analysis of EAF2 expression with immune cell infiltration and co-expression.
Main Results:
- EAF2 expression is upregulated in SKCM at both transcriptional and proteomic levels.
- EAF2 demonstrates significant diagnostic and prognostic capabilities.
- EAF2 expression correlates with immune cell infiltration (B cells, T cells, neutrophils, macrophages, dendritic cells) and CD19.
Conclusions:
- This study is the first to demonstrate that elevated EAF2 expression correlates with tumor progression and improved prognosis in SKCM.
- EAF2 may serve as a potential biomarker for diagnosing SKCM and predicting patient prognosis.
- EAF2's role in SKCM suggests potential involvement in the immune response.
Related Concept Videos
Master Transcription Regulators
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
MAPK Signaling Cascades

